I'm more excited about why two such highly qualified and experienced specialists chose Botanix.
There are numerous company's around the world experimenting in the use of marijuana and its various extracts. The areas of epilepsy and dementia to name a few.
And having such niche expertise would make them both highly sort after as members of staff.
BOT managed to get them both. I can only assume that the early evidence for achieving success in the treatment of acne is more compelling than we know.
And I also believe that the broader market is yet to hear about this little company and its goals.
I keep going back to thinking, if successful, it is a highly disruptive technology in a huge market. Not just acne, bit psoriasis and atopic dermatitis. All really debilitating illnesses in there own way.
There will be pull backs on profit taking as always, and I may even trade a few if we get a frenzy day, but overall, I'm hanging on until the clinical trials.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)